Pacific Biomarker Announces the Appointment of Maribeth Raines, Ph.D. as Vice President of Laboratory Services
SEATTLE, WA--(Nov 19, 2012) - Pacific Biomarkers (PBI), a WA-based limited liability company and provider of specialized clinical biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announces the addition of Maribeth Raines, Ph.D., as Vice President for Laboratory Services. In her role, Dr. Raines will be responsible for providing scientific leadership and technical support to the Pacific Biomarkers Operations and Research and Development Programs. She will assist with implementing new business strategies to better serve PBI's clients.
Dr. Raines brings extensive experience in biomarker discovery, development and validation to her role at Pacific Biomarkers. Most recently, Dr. Raines was Director of Scientific Affairs for Quest Diagnostics Clinical Trials. At Quest, she played a key role in expanding their services into biomarker testing and emerging markets. She has supported over 200 clinical trials for numerous pharmaceutical clients and coordinated global deployment of over 100 biomarkers and esoteric assays in China as well as other laboratories. Prior to her work in Clinical Trials, Dr. Raines served as the Director of Research and Development at both Nichols Institute Diagnostics and Biosource International (now Life Technologies) where she was responsible for reagent/assay development and manufacturing. She also served on the faculty at UCLA School of Medicine in the Radiation Oncology Division. Dr. Raines received her B.S. degree in Biology from St. Francis University, and her Ph.D. in Biochemistry from Michigan State University.
"As a key member of the Pacific Biomarkers senior management and scientific team, Dr. Raines brings significant experience and expertise which will further enhance our position in the clinical biomarker service arena," commented Michael Murphy, Ph.D., Chief Operating Officer of Pacific Biomarkers. "We look forward to Dr. Raines's leadership and insights as we expand into new areas while continuing to build on our ability to support drug development for our growing number of clients."
About Pacific Biomarkers (PBI)
Established in 1989, PBI provides clinical biomarker laboratory services and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research. The Company provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity, and nutrition. The PBI laboratory is accredited by the College of American Pathologists, New York State, and the Lipid Standardization Program. PBI clients include many of the world's largest pharmaceutical, biotech, and diagnostic companies. PBI also provides clinical biomarker services focusing on the emerging field of biomarker assay development and testing. Services include validating and performing custom assays for novel clinical biomarkers, immunogenicity testing, and multiplex testing. PBI is headquartered in Seattle, Washington.
Chief Executive Officer